12:00 AM
 | 
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Inovio preclinical data

In mice, Inovio's SynCon DNA CMV vaccine delivered with the company's electroporation system induced "strong and broad"...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >